Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides

ACS Nano

Volumn 7, Issue 10, 2013, Pages 8605-8615

  Hou, Kirk K ^a   Pan, Hua ^a   Ratner, Lee ^a   Schlesinger, Paul H ^a   Wickline, Samuel A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

drug delivery; endosomolysis; melittin; nanoparticle; siRNA

Indexed keywords

CYTOPLASMIC COMPARTMENTS; CYTOPLASMIC DELIVERY; ENDOSOMOLYSIS; MELITTIN; PEPTIDE TRANSDUCTION; SIRNA; SIRNA DELIVERY; T-CELL LEUKEMIA;

CYTOLOGY; DRUG DELIVERY; MOLECULAR BIOLOGY; NANOPARTICLES; T-CELLS;

PEPTIDES;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELITTIN; NANOPARTICLE; PEPTIDE; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMISTRY; ENDOSOME; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; ENDOSOMES; MELITTEN; MICE; MICROSCOPY, ATOMIC FORCE; MOLECULAR SEQUENCE DATA; NANOPARTICLES; NF-KAPPA B; PEPTIDES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84887009773     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn403311c     Document Type: Article

References (71)

1. Shen, H.; Sun, T.; Ferrari, M. Nanovector Delivery of siRNA for Cancer Therapy Cancer Gene Ther. 2012, 19, 367-373
2. Miele, E.; Spinelli, G. P.; Miele, E.; Di Fabrizio, E.; Ferretti, E.; Tomao, S.; Gulino, A. Nanoparticle-Based Delivery of Small Interfering RNA: Challenges for Cancer Therapy Int. J. Nanomed. 2012, 2012, 3637-3657
3. Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis Elegans Nature 1998, 391, 806-811
4. Elbashir, S. M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21-Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells Nature 2001, 411, 494-498
5. Dominska, M.; Dykxhoorn, D. M. Breaking Down the Barriers: siRNA Delivery and Endosome Escape J. Cell Sci. 2010, 123, 1183-1189
6. Guzman-Villanueva, D.; El-Sherbiny, I. M.; Herrera-Ruiz, D.; Vlassov, A. V.; Smyth, H. D. C. Formulation Approaches to Short Interfering RNA and MicroRNA: Challenges and Implications J. Pharm. Sci. 2012, 101, 4046-4066
7. Pecot, C. V.; Calin, G. A.; Coleman, R. L.; Lopez-Berestein, G.; Sood, A. K. RNA Interference in the Clinic: Challenges and Future Directions Nat. Rev. Cancer 2011, 11, 59-67
8. Wang, J.; Lu, Z.; Wientjes, M. G.; Au, J. L. S. Delivery of siRNA Therapeutics: Barriers and Carriers AAPS J. 2010, 12, 492-503
9. Rettig, G. R.; Behlke, M. A. Progress Toward in Vivo Use of siRNAs-II Mol. Ther. 2012, 20, 483-512
10. Alabi, C.; Vegas, A.; Anderson, D. Attacking the Genome: Emerging siRNA Nanocarriers from Concept to Clinic Curr. Opin. Pharm. 2012, 12, 427-433
11. Kesharwani, P.; Gajbhiye, V.; Jain, N. K. A Review of Nanocarriers for the Delivery of Small Interfering RNA Biomaterials 2012, 33, 7138-7150
12. Zhou, J.; Shum, K.-T.; Burnett, J.; Rossi, J. Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges Pharmaceuticals 2013, 6, 85-107
13. Dokka, S.; Toledo, D.; Shi, X.; Castranova, V.; Rojanasakul, Y. Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes Pharm. Res. 2000, 17, 521-525
14. Filion, M. C.; Phillips, N. C. Toxicity and Immunomodulatory Activity of Liposomal Vectors Formulated with Cationic Lipids toward Immune Effector Cells Biochim. Biophys. Acta, Biomembr. 1997, 1329, 345-356
15. Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. Toxicity of Cationic Lipids and Cationic Polymers in Gene Delivery J. Controlled Release 2006, 114, 100-109
16. Soenen, S. J. H.; Brisson, A. R.; De Cuyper, M. Addressing the Problem of Cationic Lipid-Mediated Toxicity: The Magnetoliposome Model Biomaterials 2009, 30, 3691-3701
17. Akhtar, S.; Benter, I. Toxicogenomics of Non-Viral Drug Delivery Systems for RNAi: Potential Impact on siRNA-Mediated Gene Silencing Activity and Specificity Adv. Drug Delivery Rev. 2007, 59, 164-182
18. Ballarin-Gonzalez, B.; Howard, K. A. Polycation-Based Nanoparticle Delivery of RNAi Therapeutics: Adverse Effects and Solutions Adv. Drug Delivery Rev. 2012, 64, 1717-1729
19. Abes, R.; Arzumanov, A. A.; Moulton, H. M.; Abes, S.; Ivanova, G. D.; Iversen, P. L.; Gait, M. J.; Lebleu, B. Cell-Penetrating-Peptide-Based Delivery of Oligonucleotides: An Overview Biochem. Soc. Trans. 2007, 35, 775-779
20. Hassane, F. S.; Saleh, A. F.; Abes, R.; Gait, M. J.; Lebleu, B. Cell Penetrating Peptides: Overview and Applications to the Delivery of Oligonucleotides Cell. Mol. Life Sci. 2010, 67, 715-726
21. Morris, M. C.; Deshayes, S.; Heitz, F.; Divita, G. Cell-Penetrating Peptides: From Molecular Mechanisms to Therapeutics Biol. Cell 2008, 100, 201-217
22. Meade, B. R.; Dowdy, S. F. Enhancing the Cellular Uptake of siRNA Duplexes Following Noncovalent Packaging with Protein Transduction Domain Peptides Adv. Drug Delivery Rev. 2008, 60, 530-536
23. Endoh, T.; Ohtsuki, T. Cellular siRNA Delivery Using Cell-Penetrating Peptides Modified for Endosomal Escape Adv. Drug Delivery Rev 2009, 61, 704-709
24. Laufer, S. D.; Detzer, A.; Sczakiel, G.; Restle, T. Selected Strategies for the Delivery of siRNA in Vitro and in Vivo. In RNA Technologies and Their Applications; Erdmann, V. A.; Barciszewski, J., Eds.; Springer: Berlin, 2010; pp 29-58.
25. Hoyer, J.; Neundorf, I. Peptide Vectors for the Nonviral Delivery of Nucleic Acids Acc. Chem. Res. 2012, 45, 1048-1056
26. Nakase, I.; Akita, H.; Kogure, K.; Gräslund, A.; Langel, Ü.; Harashima, H.; Futaki, S. Efficient Intracellular Delivery of Nucleic Acid Pharmaceuticals Using Cell-Penetrating Peptides Acc. Chem. Res. 2012, 45, 1132-1139
27. Veldhoen, S.; Laufer, S. D.; Restle, T. Recent Developments in Peptide-Based Nucleic Acid Delivery Int. J. Mol. Sci. 2008, 9, 1276-1320
28. Trabulo, S.; Cardoso, A. L.; Mano, M.; de Lima, M. C. P. Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems Pharmaceuticals 2010, 3, 961-993
29. Lundberg, P.; El-Andaloussi, S.; Sütlü, T.; Johansson, H.; Langel, Ü. Delivery of Short Interfering RNA Using Endosomolytic Cell-Penetrating Peptides FASEB J. 2007, 21, 2664-2671
30. Lo, S. L.; Wang, S. An Endosomolytic TAT Peptide Produced by Incorporation of Histidine and Cysteine Residues as a Nonviral Vector for DNA Transfection Biomaterials 2008, 29, 2408-2414
31. Chiu, Y.-L.; Ali, A.; Chu, C.-y.; Cao, H.; Rana, T. M. Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells Chem. Biol. 2004, 11, 1165-1175
32. Shiraishi, T.; Nielsen, P. E. Enhanced Delivery of Cell-Penetrating Peptide-Peptide Nucleic Acid Conjugates by Endosomal Disruption Nat. Protoc. 2006, 1, 633-636
33. Wooddell, C. I.; Rozema, D. B.; Hossbach, M.; John, M.; Hamilton, H. L.; Chu, Q.; Hegge, J. O.; Klein, J. J.; Wakefield, D. H.; Oropeza, C. E. et al. Hepatocyte-Targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection Mol. Ther. 2013, 21, 973-985
34. van Asbeck, A. H.; Beyerle, A.; McNeill, H.; Bovee-Geurts, P. H. M.; Lindberg, S.; Verdurmen, W. P. R.; Hällbrink, M.; Langel, Ü.; Heidenreich, O.; Brock, R. Molecular Parameters of siRNA-Cell Penetrating Peptide Nanocomplexes for Efficient Cellular Delivery ACS Nano 2013, 7, 3797-3807
35. Hou, K. K.; Pan, H.; Lanza, G. M.; Wickline, S. A. Melittin Derived Peptides for Nanoparticle Based siRNA Transfection Biomaterials 2013, 34, 3110-3119
36. Nicolás, P.; Saleta, M.; Troiani, H.; Zysler, R.; Lassalle, V.; Ferreira, M. L. Preparation of Iron Oxide Nanoparticles Stabilized with Biomolecules: Experimental and Mechanistic Issues Acta Biomater. 2013, 9, 4754-4762
37. Veldhoen, S.; Laufer, S. D.; Trampe, A.; Restle, T. Cellular Delivery of Small Interfering RNA by a Non-Covalently Attached Cell-Penetrating Peptide: Quantitative Analysis of Uptake and Biological Effect Nucleic Acids Res. 2006, 34, 6561-6573
38. Ivanov, A. I. Pharmacological Inhibition of Endocytic Pathways: Is It Specific Enough to Be Useful? In Exocytosis and Endocytosis; Ivanov, A. I., Ed.; Humana Press, 2008; pp 15-33.
39. Vercauteren, D.; Vandenbroucke, R. E.; Jones, A. T.; Rejman, J.; Demeester, J.; De Smedt, S. C.; Sanders, N. N.; Braeckmans, K. The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls Mol. Ther. 2010, 18, 561-569
40. Nakase, I.; Takeuchi, T.; Tanaka, G.; Futaki, S. Methodological and Cellular Aspects That Govern the Internalization Mechanisms of Arginine-Rich Cell-Penetrating Peptides Adv. Drug Delivery Rev. 2008, 60, 598-607
41. Xiao, Y.-T.; Xiang, L.-X.; Shao, J.-Z. Vacuolar H+-Atpase Int. J. Biochem. Cell Biol. 2008, 40, 2002-2006
42. Merion, M.; Schlesinger, P.; Brooks, R. M.; Moehring, J. M.; Moehring, T. J.; Sly, W. S. Defective Acidification of Endosomes in Chinese Hamster Ovary Cell Mutants "Cross-Resistant" to Toxins and Viruses Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 5315-5319
43. Eissenberg, L. G.; Goldman, W. E.; Schlesinger, P. H. Histoplasma Capsulatum Modulates the Acidification of Phagolysosomes J. Exp. Med. 1993, 177, 1605-1611
44. Chou, S. T.; Leng, Q.; Scaria, P.; Woodle, M.; Mixson, A. J. Selective Modification of HK Peptides Enhances siRNA Silencing of Tumor Targets in Vivo Cancer Gene Ther. 2011, 18, 707-716
45. Langlet-Bertin, B.; Leborgne, C.; Scherman, D.; Bechinger, B.; Mason, A. J.; Kichler, A. Design and Evaluation of Histidine-Rich Amphipathic Peptides for siRNA Delivery Pharm. Res. 2010, 27, 1426-1436
46. Pichon, C.; Roufaï, M. B.; Monsigny, M.; Midoux, P. Histidylated Oligolysines Increase the Transmembrane Passage and the Biological Activity of Antisense Oligonucleotides Nucleic Acids Res. 2000, 28, 504-512
47. Tanaka, K.; Kanazawa, T.; Ogawa, T.; Takashima, Y.; Fukuda, T.; Okada, H. Disulfide Crosslinked Stearoyl Carrier Peptides Containing Arginine and Histidine Enhance siRNA Uptake and Gene Silencing Int. J. Pharm. 2010, 398, 219-224
48. Yu, W.; Pirollo, K. F.; Yu, B.; Rait, A.; Xiang, L.; Huang, W.; Zhou, Q.; Ertem, G. Z.; Chang, E. H. Enhanced Transfection Efficiency of a Systemically Delivered Tumor-Targeting Immunolipoplex by Inclusion of a pH-Sensitive Histidylated Oligolysine Peptide Nucleic Acids Res. 2004, 32, e48-e48
49. Krogstad, D. J.; Schlesinger, P. H. A Perspective on Antimalarial Action: Effects of Weak Bases on Plasmodium Falciparum Biochem. Pharmacol. 1986, 35, 547-552
50. Caron, N. J.; Quenneville, S. P.; Tremblay, J. P. Endosome Disruption Enhances the Functional Nuclear Delivery of TAT-Fusion Proteins Biochem. Biophys. Res. Commun. 2004, 319, 12-20
51. Alabi, C. A.; Love, K. T.; Sahay, G.; Stutzman, T.; Young, W. T.; Langer, R.; Anderson, D. G. FRET-Labeled siRNA Probes for Tracking Assembly and Disassembly of siRNA Nanocomplexes ACS Nano 2012, 6, 6133-6141
52. Geoghegan, J. C.; Gilmore, B. L.; Davidson, B. L. Gene Silencing Mediated by siRNA-Binding Fusion Proteins Is Attenuated by Double-Stranded RNA-Binding Domain Structure Mol. Ther.-Nucleic Acids 2012, 1, e53
53. Rauch, D. A.; Ratner, L. Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients Viruses 2011, 3, 886-900
54. Keutgens, A.; Robert, I.; Viatour, P.; Chariot, A. Deregulated NF-κB Activity in Haematological Malignancies Biochem. Pharmacol. 2006, 72, 1069-1080
55. Horie, R. NF-κB in Pathogenesis and Treatment of Adult T-Cell Leukemia/Lymphoma Int. Rev. Immunol. 2007, 26, 269-281
56. Dewan, M. Z.; Terashima, K.; Taruishi, M.; Hasegawa, H.; Ito, M.; Tanaka, Y.; Mori, N.; Sata, T.; Koyanagi, Y.; Maeda, M. et al. Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel Nod-Scid/Γcnull Mice: Suppression by an Inhibitor against NF-κB J. Virol. 2003, 77, 5286-5294
57. Mori, N.; Yamada, Y.; Ikeda, S.; Yamasaki, Y.; Tsukasaki, K.; Tanaka, Y.; Tomonaga, M.; Yamamoto, N.; Fujii, M. Bay 11-7082 Inhibits Transcription Factor Nf-KB and Induces Apoptosis of HTLV-I-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells Blood 2002, 100, 1828-1834
58. Shu, S. T.; Nadella, M. V. P.; Dirksen, W. P.; Fernandez, S. A.; Thudi, N. K.; Werbeck, J. L.; Lairmore, M. D.; Rosol, T. J. A Novel Bioluminescent Mouse Model and Effective Therapy for Adult T-Cell Leukemia/Lymphoma Cancer Res. 2007, 67, 11859-11866
59. Mitra-Kaushik, S.; Harding, J. C.; Hess, J. L.; Ratner, L. Effects of the Proteasome Inhibitor PS-341 on Tumor Growth in HTLV-1 Tax Transgenic Mice and Tax Tumor Transplants Blood 2004, 104, 802-809
60. Hajj, H. E.; El-Sabban, M.; Hasegawa, H.; Zaatari, G.; Ablain, J.; Saab, S. T.; Janin, A.; Mahfouz, R.; Nasr, R.; Kfoury, Y. et al. Therapy-Induced Selective Loss of Leukemia-Initiating Activity in Murine Adult T Cell Leukemia J. Exp. Med. 2010, 207, 2785-2792
61. Watanabe, M.; Ohsugi, T.; Shoda, M.; Ishida, T.; Aizawa, S.; Maruyama-Nagai, M.; Utsunomiya, A.; Koga, S.; Yamada, Y.; Kamihira, S. et al. Dual Targeting of Transformed and Untransformed HTLV-1-Infected T Cells by DHMEQ, a Potent and Selective Inhibitor of NF-κB, as a Strategy for Chemoprevention and Therapy of Adult T-Cell Leukemia Blood 2005, 106, 2462-2471
62. Shi, B.; Keough, E.; Matter, A.; Leander, K.; Young, S.; Carlini, E.; Sachs, A. B.; Tao, W.; Abrams, M.; Howell, B. et al. Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-Mediated Delivery J. Histochem. Cytochem. 2011, 59, 727-740
63. Zuckerman, J. E.; Choi, C. H. J.; Han, H.; Davis, M. E. Polycation-siRNA Nanoparticles Can Disassemble at the Kidney Glomerular Basement Membrane Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 3137-3142
64. Thiele, L.; Diederichs, J. E.; Reszka, R.; Merkle, H. P.; Walter, E. Competitive Adsorption of Serum Proteins at Microparticles Affects Phagocytosis by Dendritic Cells Biomaterials 2003, 24, 1409-1418
65. Ogawara, K.-I.; Furumoto, K.; Nagayama, S.; Minato, K.; Higaki, K.; Kai, T.; Kimura, T. Pre-Coating with Serum Albumin Reduces Receptor-Mediated Hepatic Disposition of Polystyrene Nanosphere: Implications for Rational Design of Nanoparticles J. Controlled Release 2004, 100, 451-455
66. Bernal-Mizrachi, L.; Lovly, C. M.; Ratner, L. The Role of NF-κB-1 and NF-κB-2-Mediated Resistance to Apoptosis in Lymphomas Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 9220-9225
67. Kitajima, I.; Shinohara, T.; Bilakovics, J.; Brown, D.; Xu, X.; Nerenberg, M. Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-Kappa B Science 1992, 258, 1792-1795
68. Raper, S. E.; Chirmule, N.; Lee, F. S.; Wivel, N. A.; Bagg, A.; Gao, G.-P.; Wilson, J. M.; Batshaw, M. L. Fatal Systemic Inflammatory Response Syndrome in a Ornithine Transcarbamylase Deficient Patient Following Adenoviral Gene Transfer Mol. Genet. Metab. 2003, 80, 148-158
69. Hacein-Bey-Abina, S.; Kalle, C. V.; Schmidt, M.; McCormack, M. P.; Wulffraat, N.; Leboulch, P.; Lim, A.; Osborne, C. S.; Pawliuk, R.; Morillon, E. et al. LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for Scid-X1 Science 2003, 302, 415-419
70. Ahn, M.; Witting, S. R.; Ruiz, R.; Saxena, R.; Morral, N. Constitutive Expression of Short Hairpin RNA in Vivo Triggers Buildup of Mature Hairpin Molecules Hum. Gene Ther. 2011, 22, 1483-1497
71. Rauch, D.; Gross, S.; Harding, J.; Niewiesk, S.; Lairmore, M.; Piwnica-Worms, D.; Ratner, L. Imaging Spontaneous Tumorigenesis: Inflammation Precedes Development of Peripheral NK Tumors Blood 2009, 113, 1493-1500